An older man (71) with hypertension and a 25% 10-year ASCVD risk should be started on which statin intensity?

Prepare for the ACCSAP CCKE Coronary Artery Disease Test. Use flashcards and multiple choice questions, complete with hints and explanations. Ensure success on your test!

Multiple Choice

An older man (71) with hypertension and a 25% 10-year ASCVD risk should be started on which statin intensity?

Explanation:
The key idea is using estimated 10-year ASCVD risk to guide statin intensity for primary prevention. When the predicted risk is high (around 20% or more), the benefit of intensive LDL lowering with a high‑intensity statin is substantial, helping to prevent heart attacks and strokes. In a 71-year-old man with hypertension and a 25% 10-year ASCVD risk, starting a high-intensity statin is appropriate because it maximizes the absolute risk reduction. This typically involves a potent statin at higher doses (for example, atorvastatin 40–80 mg or rosuvastatin 20–40 mg daily). Starting a moderate- or low-intensity statin would yield less LDL lowering and less potential risk reduction, and choosing no statin would miss a clear preventive opportunity given his high estimated risk. Age alone isn’t a reason to avoid statins here; the high risk drives selecting a high-intensity regimen, assuming there are no contraindications.

The key idea is using estimated 10-year ASCVD risk to guide statin intensity for primary prevention. When the predicted risk is high (around 20% or more), the benefit of intensive LDL lowering with a high‑intensity statin is substantial, helping to prevent heart attacks and strokes. In a 71-year-old man with hypertension and a 25% 10-year ASCVD risk, starting a high-intensity statin is appropriate because it maximizes the absolute risk reduction. This typically involves a potent statin at higher doses (for example, atorvastatin 40–80 mg or rosuvastatin 20–40 mg daily).

Starting a moderate- or low-intensity statin would yield less LDL lowering and less potential risk reduction, and choosing no statin would miss a clear preventive opportunity given his high estimated risk. Age alone isn’t a reason to avoid statins here; the high risk drives selecting a high-intensity regimen, assuming there are no contraindications.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy